Achmea Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,934
Closed -$7.41M 419
2024
Q3
$7.41M Sell
15,934
-20,656
-56% -$9.61M 0.12% 186
2024
Q2
$17.2M Sell
36,590
-13,644
-27% -$6.4M 0.31% 81
2024
Q1
$21M Buy
50,234
+2,555
+5% +$1.07M 0.4% 65
2023
Q4
$19.4M Sell
47,679
-8,728
-15% -$3.55M 0.4% 59
2023
Q3
$19.6M Buy
56,407
+235
+0.4% +$81.7K 0.43% 51
2023
Q2
$19.8M Buy
56,172
+5,893
+12% +$2.07M 0.42% 56
2023
Q1
$15.8M Sell
50,279
-1,115
-2% -$351K 0.46% 50
2022
Q4
$13.9M Buy
51,394
+1,154
+2% +$312K 0.47% 48
2022
Q3
$14.5M Buy
50,240
+12,680
+34% +$3.67M 0.51% 40
2022
Q2
$10.6M Buy
37,560
+1,428
+4% +$402K 0.34% 64
2022
Q1
$9.43M Buy
+36,132
New +$9.43M 0.25% 99
2021
Q4
Sell
-37,930
Closed -$6.88M 646
2021
Q3
$6.88M Sell
37,930
-2,988
-7% -$542K 0.21% 135
2021
Q2
$8.25M Buy
40,918
+24,984
+157% +$5.04M 0.28% 93
2021
Q1
$3.42M Hold
15,934
0.12% 228
2020
Q4
$3.77M Hold
15,934
0.14% 189
2020
Q3
$4.34M Sell
15,934
-22,350
-58% -$6.08M 0.18% 149
2020
Q2
$11.1M Buy
+38,284
New +$11.1M 0.38% 60
2020
Q1
Sell
-14,663
Closed -$3.21M 551
2019
Q4
$3.21M Hold
14,663
0.12% 189
2019
Q3
$2.48M Hold
14,663
0.1% 228
2019
Q2
$2.69M Sell
14,663
-368
-2% -$67.5K 0.1% 226
2019
Q1
$2.77M Hold
15,031
0.12% 200
2018
Q4
$2.49M Buy
15,031
+720
+5% +$119K 0.12% 197
2018
Q3
$2.76M Sell
14,311
-2,612
-15% -$503K 0.1% 225
2018
Q2
$2.88M Hold
16,923
0.1% 235
2018
Q1
$2.76M Hold
16,923
0.09% 248
2017
Q4
$2.54M Buy
16,923
+5,420
+47% +$812K 0.09% 268
2017
Q3
$1.75M Buy
11,503
+2,835
+33% +$431K 0.1% 257
2017
Q2
$1.12M Buy
8,668
+3,507
+68% +$452K 0.07% 316
2017
Q1
$564K Buy
+5,161
New +$564K 0.03% 427